Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19891 AL 19905

Potential therapeutic agents against Alzheimer's disease from natural sources

Park SY.

Arch Pharm Res. 2010 Oct;33(10):1589-609. doi: 10.1007/s12272-010-1010-y. Epub 2010 Oct 30.

Induction of Alzheimer's-like changes in brain of mice expressing mutant APP fed excess methionine

McCampbell A, Wessner K, Marlatt MW, Wolffe C, Toolan D, Podtelezhnikov A, Yeh S, Zhang R, Szczerba P, Tanis KQ, Majercak J, Ray WJ, Savage M.

J Neurochem. 2011 Jan;116(1):82-92. doi: 10.1111/j.1471-4159.2010.07087.x. Epub 2010 Dec 2.

Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease

Salminen A, Ojala J, Kaarniranta K, Hiltunen M, Soininen H.

Prog Neurobiol. 2011 Jan;93(1):99-110. doi: 10.1016/j.pneurobio.2010.10.006. Epub 2010 Nov 5.

Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative

Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR Jr, Weiner M, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2010 Nov;67(11):1370-8. doi: 10.1001/archneurol.2010.284.

A meta-analysis of mood stabilizers for Alzheimer's disease

Xiao H, Su Y, Cao X, Sun S, Liang Z.

J Huazhong Univ Sci Technolog Med Sci. 2010 Oct;30(5):652-8. doi: 10.1007/s11596-010-0559-5. Epub 2010 Nov 10.

Amyloid-independent mechanisms in Alzheimer's disease pathogenesis

Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH.

J Neurosci. 2010 Nov 10;30(45):14946-54. doi: 10.1523/JNEUROSCI.4305-10.2010.

Natural products as a source of Alzheimer's drug leads

Williams P, Sorribas A, Howes MJ.

Nat Prod Rep. 2011 Jan;28(1):48-77. doi: 10.1039/c0np00027b. Epub 2010 Nov 12.

Advances in perfusion magnetic resonance imaging in Alzheimer's disease

Chen W, Song X, Beyea S, D'Arcy R, Zhang Y, Rockwood K.

Alzheimers Dement. 2011 Mar;7(2):185-96. doi: 10.1016/j.jalz.2010.04.004. Epub 2010 Nov 11.

Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice

Li S, He H, Cui W, Gu B, Li J, Qi Z, Zhou G, Liang CM, Feng XY.

Anat Rec (Hoboken). 2010 Dec;293(12):2136-43. doi: 10.1002/ar.21209.

Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease

Panza F, Frisardi V, Imbimbo BP, D'Onofrio G, Pietrarossa G, Seripa D, Pilotto A, Solfrizzi V.

Immunotherapy. 2010 Nov;2(6):767-82. doi: 10.2217/imt.10.80.

Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure

Hahn S, Brüning T, Ness J, Czirr E, Baches S, Gijsen H, Korth C, Pietrzik CU, Bulic B, Weggen S.

J Neurochem. 2011 Feb;116(3):385-95. doi: 10.1111/j.1471-4159.2010.07118.x. Epub 2010 Dec 13.

Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

Ringman JM, Gylys KH, Medina LD, Fox M, Kepe V, Flores DL, Apostolova LG, Barrio JR, Small G, Silverman DH, Siu E, Cederbaum S, Hecimovic S, Malnar M, Chakraverty S, Goate AM, Bird TD, Leverenz JB.

Neurosci Lett. 2011 Jan 10;487(3):287-92. doi: 10.1016/j.neulet.2010.10.039. Epub 2010 Nov 19.

Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial

Wessels AM, Pollock BG, Anyama NG, Schneider LS, Lieberman JA, Marder SR, Bies RR.

J Clin Psychopharmacol. 2010 Dec;30(6):683-7. doi: 10.1097/jcp.0b013e3181fa05bb.

Validation of the neurobehavioral cognitive status examination and the Rivermead Behavioural Memory Test in investigations of dementia

Johansson M, Wressle E.

Scand J Occup Ther. 2012 May;19(3):282-7. doi: 10.3109/11038128.2010.528789. Epub 2010 Nov 25.

Small vascular and Alzheimer disease-related pathologic determinants of dementia in the oldest-old

Sinka L, Kövari E, Gold G, Hof PR, Herrmann FR, Bouras C, Giannakopoulos P.

J Neuropathol Exp Neurol. 2010 Dec;69(12):1247-55. doi: 10.1097/NEN.0b013e3181ffc3b9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias